Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesRepeat prostate biopsy — when, where, and how
Urologic Oncology: Seminars and Original Investigations, 06/29/09
Presti JC - In a review of the indications and techniques in pts undergoing a repeat biopsy, it appears that in pts for whom repeat biopsies fail to identify cancer, yet clinical suspicion remains high, consideration for a saturation biopsy approach seems warranted.
Methods- Pts who have a persistently elevated or a rising PSA level following a prior negative prostate biopsy can be a stressful situation for both urologist and pt.
- In pts with a prior negative biopsy, assessing the adequacy of the initial biopsy is important.
- F/T PSA is currently the most useful marker in predicting cancer on repeat biopsy, although newer markers, such as PCA3, are promising.
- Repeat biopsies should include a minimum of 14 cores, the 12 cores recommended for an initial biopsy and 2 additional cores obtained from the right and left anterior apex.
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Bacterial Sepsis After Prostate Biopsy—A New Perspective
Urology, 10/21/09
Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence
Journal of Clinical Oncology, 11/02/09
Sonographic detection of renal and ureteral stones. Value of the twinkling sign
International Braz J Urol, 10/30/09
Article Search
Sponsor